| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 65 |
| 1 | METHOTREXATE SODIUM | 49 |
| 2 | METHOTREXATE | 47 |
| 3 | ACETAMINOPHEN | 32 |
| 4 | TACROLIMUS | 32 |
| 5 | DEXAMETHASONE | 31 |
| 6 | DEXAMETHASONE 1.5 MG | 31 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 31 |
| 8 | TACROLIMUS OINTMENT 0.1% | 31 |
| 9 | CYTARABINE | 25 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXTRAN 40 | 1 | 0.0139 |
| 1 | FERROUS FUMARATE AND POLYSACCHRIDE IRON COMPLEX AND FOLIC ACID | 1 | 0.0104 |
| 2 | ANORECTAL OINTMENT | 2 | 0.0091 |
| 3 | ALUMINUM HYDROXIDE GEL | 1 | 0.0068 |
| 4 | ALOE FEROX LEAF | 1 | 0.0055 |
| 5 | NALBUPHINE HYDROCHLORIDE | 1 | 0.0044 |
| 6 | HYPROMELLOSE | 7 | 0.0029 |
| 7 | INTERLEUKIN-10 | 1 | 0.0028 |
| 8 | LUMASIRAN | 1 | 0.0026 |
| 9 | LOTEPREDNOL ETABONATE AND TOBRAMYCIN | 1 | 0.0025 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 120 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 51 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 47 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 47 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 35 |
| 5 | Alkylating Drug [EPC] | 34 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 33 |
| 7 | Azole Antifungal [EPC] | 28 |
| 8 | Kinase Inhibitor [EPC] | 24 |
| 9 | BCL-2 Inhibitor [EPC] | 23 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD33-directed Immunoconjugate [EPC] | 6 | 0.0016 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 10 | 0.0011 |
| 2 | Tyrosine Kinase 2 Inhibitor [EPC] | 2 | 0.0007 |
| 3 | Provitamin D2 Compound [EPC] | 19 | 0.0006 |
| 4 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 6 | Ectoparasiticide [EPC] | 2 | 0.0005 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 11 | 0.0005 |
| 8 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 9 | Asparagine-specific Enzyme [EPC] | 6 | 0.0004 |